News

Sasol Limited Financial Performance Overview for Half Year 2024

Sasol Limited Financial Performance Overview for Half Year 2024

Sasol Limited's Financial Performance Review

Sasol Limited's recent financial results for the six-month period ending December 2024 illustrate the complexities of operating in a challenging market. Despite adverse conditions, the company showcased resilience through stringent cost controls and efficient capital management, notably enhancing free cash flow compared to the previous year.

Revenue and Sales Performance

The total revenue recorded was R122.1 billion, representing a ten percent decline from the same period in the previous year. This reduction was primarily driven by a thirteen percent drop in the average Brent crude oil price per barrel and decreased refining margins. Additionally, a five percent fall in sales volumes reflected both reduced production and weakened market demand.

Profitability Metrics

Sasol's adjusted earnings before interest, tax, depreciation, and amortisation (EBITDA) was reported at R23.9 billion, showing a fifteen percent decrease relative to last year. This decline is attributed to the aforementioned revenue decrease; however, strategic cost management helped in mitigating losses. Notably, the international chemicals segment's contribution increased significantly from six percent to thirteen percent.

Key Earnings Analysis

Earnings before interest and tax (EBIT) plummeted by forty percent to R9.5 billion, significantly impacted by non-cash factors. These included a net loss of R6.2 billion from asset remeasurements and unrealised losses on the translation of monetary assets and derivatives.

Earnings Per Share Breakdown

Basic earnings per share (EPS) saw a sharp decrease of fifty-two percent, dropping to R7.22, while headline earnings per share (HEPS) fell by thirty-one percent to R14.13. These figures illustrate the substantial impact of the challenging economic environment on shareholder returns.

Cash Flow and Capital Expenditures

Sasol reported a 20% increase in operating cash flow, which rose to R17.6 billion, driven largely by working capital changes. Capital expenditure for the period was recorded at R15.0 billion, a six percent decrease from last year. This disciplined approach to spending reflects Sasol's commitment to preserving cash in uncertain times.

Debt and Financial Health

As of December 31, 2024, Sasol's total debt stood at R116.9 billion (approximately $6.2 billion), which is a slight decrease from R117.7 billion ($6.5 billion) at mid-2024. The net debt, excluding leases, increased from R73.7 billion ($4.1 billion) to R81.8 billion ($4.3 billion), which underscores the company's cautious financial management amidst economic fluctuations.

Dividend Policy

The board of directors of Sasol Limited decided not to declare any interim dividends during this reporting period. This decision aligns with their policy of distributing 30% of cash flow, considering that free cash flow was negative, and net debt exceeded their sustainability threshold.

Requirements for Future Dividends

Future dividend declarations hinge on restoring positive free cash flow and maintaining net debt below $4 billion in a sustainable manner. Sasol's prudent financial strategies indicate their focus on stabilizing the company's fiscal health before returning to dividend payments.

Conclusion and Outlook

Sasol Limited's performance for the first half of the financial year reflects the complex dynamics of the current market landscape. The decline in key metrics, while concerning, is offset by strategic cost management and improvements in cash flow generation. Moving forward, the company aims to navigate these challenges while exploring opportunities for growth and recovery.

Frequently Asked Questions

What were Sasol's financial results for the first half of 2024?

Sasol reported a revenue of R122.1 billion, a decrease of ten percent from the previous year, affected by lower oil prices and demand.

How much did Sasol's EBITDA change?

The adjusted EBITDA decreased to R23.9 billion, a reduction of fifteen percent compared to the same period last year.

What is the status of Sasol's dividend policy?

No interim dividend was declared, aligning with their policy due to negative free cash flow and high net debt levels.

How has Sasol managed its capital expenditures?

Sasol reduced capital expenditures to R15.0 billion, maintaining a focus on cash preservation in a volatile market.

What are the future expectations for Sasol's performance?

Sasol aims to stabilize financial metrics and remain focused on strategic growth, while managing costs effectively to enhance profitability.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 257

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 35

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 50

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 85

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 52

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 110

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

DESRI Completes Major Financing for Texas Solar Projects

Updated Category News Views 324

DESRI Completes Major Financing for Texas Solar Projects Today, DESRI proudly announced that it has closed a significant preferred equity financing of $129 million aimed at a 250-megawatt (MWac) solar development portfolio. This portfolio consists of two innovative solar projects located in West Texas, an area ripe for renewable energy enhancement. Meeting Industrial...

Continue Reading
Colossal Foundation Invests $500,000 in Condor Restoration Efforts

Updated Category News Views 76

Colossal Foundation Invests in Wildlife Recovery The Colossal Foundation has made a significant commitment of $500,000 towards restoring the California condor to its ancestral skies. This incredible movement represents a decade-long partnership with the Nez Perce Tribe, focusing on the recovery and reintroduction of North America’s largest land bird. For more than a...

Continue Reading
Revolutionary Self-Healing Film: The Future of Waterproofing

Updated Category News Views 108

Revolutionary Waterproofing Solutions by Charter Next Generation Charter Next Generation (CNG) recently unveiled its groundbreaking Nail Sealable film technology, designed to transform waterproofing in the construction industry. This pioneering self-healing film stands out with its exceptional moisture resistance and remarkable durability, making it a game changer for...

Continue Reading
Sonnet BioTherapeutics Provides Positive Safety Insights on SON-1010

Updated Category News Views 273

Exciting Safety Data from Sonnet BioTherapeutics’ SON-1010 Trial Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) has unveiled impressive topline safety data following a successful dose escalation of SON-1010 in the Phase 1 SB101 clinical trial. The study focused on the administration of SON-1010 to patients suffering from advanced solid tumors, marking a significant...

Continue Reading
Key Legal Information for Symbotic Inc. Shareholders

Updated Category News Views 73

Important Information for Symbotic Inc. Investors Recent developments surrounding Symbotic Inc. have captured the attention of investors globally. Investors who are shareholders of Symbotic Inc. (NASDAQ: SYM) may need to be aware of significant deadlines regarding a recent securities class action lawsuit. Overview of the Lawsuit Investors are reminded that they may have...

Continue Reading